Redsense Medical AB (publ) logo

REDS - Redsense Medical AB (publ) Share Price

SEK47.8 -1.4  -2.8%

Last Trade - 4:29pm

Sector
Healthcare
Size
Small Cap
Market Cap £54.0m
Enterprise Value £53.4m
Revenue £1.63m
Position in Universe 973rd / 1772
Bullish
Bearish
Unlock REDS Revenue
Momentum
Relative Strength (%)
1m +1.96%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -16.3%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
198.8
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
2.22 2.05 4.77 1.49 7.01 13.3 21.0 27.0 +43.0%
+900
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2020, Redsense Medical AB (publ) revenues increased from SEK4.8M to SEK10.2M. Net income totaled SEK371K vs. loss of SEK2.5M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects Interest Income / Expenses Net increase from SEK19K to SEK152K (income), Interest Expense etc. decrease of 60% to SEK54K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

REDS Revenue Unlock REDS Revenue

Net Income

REDS Net Income Unlock REDS Revenue

Normalised EPS

REDS Normalised EPS Unlock REDS Revenue

PE Ratio Range

REDS PE Ratio Range Unlock REDS Revenue

Dividend Yield Range

REDS Dividend Yield Range Unlock REDS Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
REDS EPS Forecasts Unlock REDS Revenue
Profile Summary

Redsense Medical AB (publ) is a Sweden-based company, which is primarily involved in the healthcare industry. The Company is active within the field of hemodialysis. It operates as a manufacturer of blood loss detection device that is designed to alarm on blood leakage from the venous blood access. The Company's Redsense system consists of an alarm unit, an extension fiber and a non invasive sensor patch. When the sensor patch is placed over the blood access, it detects any blood coming in contact with the sensor. This can occur if the needle is accidentally dislodged or if blood is leaking during dialysis. The Redsense system is designed to alarm when blood reaches the sensor, so the dialysis caregiver or observing person at home, can apply appropriate action when a venous needle dislodges.

Directors
Last Annual December 31st, 2019
Last Interim June 30th, 2020
Public Since June 17, 2015
No. of Shareholders: n/a
No. of Employees: 5
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange AktieTorget Stock Exchange
Shares in Issue 12,540,810
Free Float (0.0%)
Eligible for
ISAs
SIPPs
REDS Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for REDS
Upcoming Events for REDS
Frequently Asked Questions for Redsense Medical AB (publ)
What is the Redsense Medical AB (publ) share price?

As of 4:29pm, shares in Redsense Medical AB (publ) are trading at SEK47.8, giving the company a market capitalisation of £54.0m. This share price information is delayed by 15 minutes.

How has the Redsense Medical AB (publ) share price performed this year?

Shares in Redsense Medical AB (publ) are currently trading at SEK47.8 and the price has moved by 0.321k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Redsense Medical AB (publ) price has moved by 0.357k% over the past year.

What are the analyst and broker recommendations for Redsense Medical AB (publ)?

Of the analysts with advisory recommendations for Redsense Medical AB (publ), there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for Redsense Medical AB (publ) is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will Redsense Medical AB (publ) next release its financial results?

Redsense Medical AB (publ) is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Redsense Medical AB (publ) dividend yield?

Redsense Medical AB (publ) does not currently pay a dividend.

Does Redsense Medical AB (publ) pay a dividend?

Redsense Medical AB (publ) does not currently pay a dividend.

When does Redsense Medical AB (publ) next pay dividends?

Redsense Medical AB (publ) does not currently pay a dividend.

How do I buy Redsense Medical AB (publ) shares?

To buy shares in Redsense Medical AB (publ) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Redsense Medical AB (publ)?

Shares in Redsense Medical AB (publ) are currently trading at SEK47.8, giving the company a market capitalisation of £54.0m.

Where are Redsense Medical AB (publ) shares listed? Where are Redsense Medical AB (publ) shares listed?

Here are the trading details for Redsense Medical AB (publ):

Country of listing: Sweden
Exchange: AKT
Ticker Symbol: REDS
What kind of share is Redsense Medical AB (publ)?

Based on an overall assessment of its quality, value and momentum, Redsense Medical AB (publ) is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Redsense Medical AB (publ) share price forecast 2020?

We were not able to load any forecast data for Redsense Medical AB (publ).

How can I tell whether the Redsense Medical AB (publ) share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Redsense Medical AB (publ). Over the past six months, the relative strength of its shares against the market has been 0.246k%. At the current price of SEK47.8, shares in Redsense Medical AB (publ) are trading at 89.49% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Redsense Medical AB (publ) PE Ratio?

We were not able to find PE ratio data for Redsense Medical AB (publ).

Who are the key directors of Redsense Medical AB (publ)?

Redsense Medical AB (publ)'s management team is headed by:

Patrik Byhmer - CEO
Brendan Kane - DSL
Jane Hurst - OTH
Bo Uneus - CHM
Klas Arildsson - IND
Jorgen Hegbrant - IND
Susanne Olausson - DRC
Maria Alquist - IND
Who are the major shareholders of Redsense Medical AB (publ)?

Here are the top five shareholders of Redsense Medical AB (publ) based on the size of their shareholding:

Similar to REDS
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.